


Case Report: Hydralazine-Induced ANCA-Associated Vasculitis

Longer Rituximab Therapy Boosts Remission in ANCA-Associated Vasculitis
ANCA-Associated Vasculitis Trial Results May Change Standard of Care

Study Probes Whether Belimumab Can Lower Vasculitis Relapse Rate

Thinking Big, Thinking Small

Research Shows Genetic Links in ANCA-Associated Vasculitis

AAV Remission Study: Does Rituximab or Azathioprine Work Best?

Rituximab Maintenance Study: Is Fixed-Schedule or Tailored Dosing Best?
